Northwest Biotherapeutics Inc
NWBO· OTC
NWBONorthwest Biotherapeutics Inc
Filed Feb 28, 2023 · 10-K · 59 days after period end · 0001410578-23-000185
derived · Computed from the longer spans the company filed.
| Metric | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures | Q4 2019dderived from reported figures |
|---|---|---|---|---|
| Revenue | $597.00K | $0.00 | $503.00K | $897.00K |
| Net Income | -$28.30M | $133.32M | -$280.50M | $6.67M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Northwest Biotherapeutics Inc · CIK 1072379 · Engraved from SEC EDGAR
ended Dec 31, 2022 · filed Feb 28, 2023 · 59 d after period end
